Healthcare information provider Wolters Kluwer Health (WK Health), US, has announced a joint venture with leading China drug information provider Medicom to deliver clinical decision support to doctors in China as the country prepares for significant changes to its healthcare system. The deal allows WK Health to expand its market-leading Clinical Decision Support (CDS) and drug information business into the rapidly growing China market and creates a needed drug information infrastructure in China.
The announcement comes as the Chinese government is focused on healthcare reform to conform standards of care and an increasing number of doctors in China prepare to pursue graduate school degrees.
Medicom, located in the city of Chengdu in the Sichuan Province, has a strong footprint in the China healthcare market, providing drug information and services. Its products and services are highly complementary to those of Wolters Kluwer Health's Clinical Solutions business, which offers healthcare professionals fast access to evidence-based medical information that helps clinicians effectively manage patient care on a daily basis. The combined offering is projected to create a robust library of clinical content that physicians can access at the point of learning as well as at the point of care with patients.
As part of the agreement, Wolters Kluwer Health will have a controlling interest in the joint venture. Terms of the deal were not disclosed.
Search for more Decision Support Tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
